1-3 of 3
Nobuyoshi Hanaoka, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pretreatment of Low-Dose Decitabine to Leukemia Cells Markedly Enhances the Cytotoxicity of Gemtuzumab Ozogamicin

Miwa Kurimoto, MD, Hiroshi Matsuoka, MD, PhD, Nobuyoshi Hanaoka, MD, PhD, Shima Uneda, MD, PhD, Takashi Sonoki, MD, PhD, Hideki Nakakuma, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 5000.
https://doi.org/10.1182/blood.V118.21.5000.5000
Published: 2011
Journal Articles

NKG2D-Mediated Marrow Injury in Paroxysmal Nocturnal Hemoglobinuria and Its Related Disorders.

Nobuyoshi Hanaoka, MD, PhD, Tatsuya Kawaguchi, MD, PhD, Kentaro Horikawa, MD, PhD, Shoichi Nagakura, MD, PhD, Sonoko Ishihara, MD, PhD, Yasuchika Tsuzuki, MD, Yuji Yonemura, MD, PhD, Hideki Nakakuma, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 3674.
https://doi.org/10.1182/blood.V110.11.3674.3674
Published: 2007
Journal Articles

ULBP and MICA/B as Novel Indicators for Both Diagnosis of Immune-Mediated Marrow Injury and Favorable Response to Immunosuppressive Therapy in Bone Marrow Failure Syndromes.

Nobuyoshi Hanaoka, MD, PhD, Tatsuya Kawaguchi, MD, PhD, Kentaro Horikawa, MD, PhD, Shoichi Nagakura, MD, PhD, Yasuchika Tsuzuki, MD, Yuji Yonemura, MD, PhD, Hideki Nakakuma, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 990.
https://doi.org/10.1182/blood.V108.11.990.990
Published: 2006